ClearVoice Sound-processing Strategy for AB HiRes 120 Cochlear Implant Users
NCT ID: NCT01066780
Last Updated: 2020-07-22
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
48 participants
INTERVENTIONAL
2010-03-31
2010-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Evaluation of a Cochlear Implant Sound Processor
NCT04237207
Investigating Auditory Processing in the Users of Auditory Brainstem and Cochlear Implants
NCT05810220
Evaluation of a HiRes™ Optima Sound Processing Strategy for the HiResolution™ Bionic Ear
NCT01616576
Impact of Anatomy-Based Cochlear Implant Programming on Early Performance
NCT06734039
Improved Speech Recognition Performance in Noise by Encoding Binaural Spatial Cues to the Cochlear Implant User.
NCT04357704
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A: ClearVoice Medium
Chronic use of ClearVoice MEDIUM for two weeks followed by chronic use of ClearVoice HIGH for two weeks.
ClearVoice
ClearVoice is a sound processing strategy designed to improve listening ability in some challenging everyday listening environments for users of the Harmony® HiResolution® Bionic Ear System (Harmony®)
Group B: ClearVoice High
Chronic use of ClearVoice HIGH for two weeks followed by chronic use of ClearVoice MEDIUM for two weeks.
ClearVoice
ClearVoice is a sound processing strategy designed to improve listening ability in some challenging everyday listening environments for users of the Harmony® HiResolution® Bionic Ear System (Harmony®)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ClearVoice
ClearVoice is a sound processing strategy designed to improve listening ability in some challenging everyday listening environments for users of the Harmony® HiResolution® Bionic Ear System (Harmony®)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* experienced (6 months device use),
* adult users of the Harmony HiResolution Bionic Ear System and HiRes Fidelity 120 sound processing.
* English language proficiency
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Advanced Bionics
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
House Ear Clinic
Los Angeles, California, United States
Carle Clinic Association
Urbana, Illinois, United States
University of Kentucky
Lexington, Kentucky, United States
The Johns Hopkins University
Baltimore, Maryland, United States
Mayo Clinic
Rochester, Minnesota, United States
Midwest Ear Institute
Kansas City, Missouri, United States
Washington University Medical Center
St Louis, Missouri, United States
Medical University of South Carolina
Charleston, South Carolina, United States
Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Nova Scotia Hearing and Speech Centres
Halifax, Nova Scotia, Canada
Sunnybrook Health Sciences Centre
Toronto, , Canada
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR0309
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.